EP Patent

EP4516301A3 — Nitrile-containing compounds for use as medicaments

Assigned to Pfizer Inc · Expires 2025-04-02 · 1y expired

What this patent protects

The invention relates to specific compounds which are useful in treating coronavirus infections such as COVID-19.

USPTO Abstract

The invention relates to specific compounds which are useful in treating coronavirus infections such as COVID-19.

Drugs covered by this patent

Paxlovid (Copackaged) (Nirmatrelvir) · Pfizer

Patent Metadata

Patent number: EP4516301A3
Jurisdiction: EP
Classification: —
Expires: 2025-04-02
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.